 |
Recombinant adeno-associated virus (serotype 2) (rAAV2) gene transfer agent expressing RPE65 |
|---|---|
| Trade Name | |
| Orphan Indication | Leber congenital amaurosis |
| USA Market Approval | USA |
| USA Designation Date | 2009-05-11 00:00:00 |
| Sponsor | AmpliPhi Biosciences Corporation;601 Union St., Suite 4200;Seattle, Washington, 98111 |
